Jolanta Slawska
Munich, BY 81675, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma.
Journal: Blood advances
Published: June 15, 2021
Genetic alterations of the SUMO isopeptidase SENP6 drive lymphomagenesis and genetic instability in diffuse large B-cell lymphoma.
Journal: Nature communications
Published: August 26, 2020
SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.
Journal: Gut
Published: November 02, 2018
Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: November 09, 2017
Functional imaging in combination with mutation status aids prediction of response to inhibiting B-cell receptor signaling in lymphoma.
Journal: Oncotarget
Published: April 28, 2017
USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma.
Journal: EMBO molecular medicine
Published: June 19, 2016
Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphoma.
Journal: OncoTargets and therapy
Published: June 13, 2014
PERIOD1 coordinates hippocampal rhythms and memory processing with daytime.
Journal: Hippocampus
Published: October 23, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026